Archive | E-WorkBook RSS feed for this section

Data today, discovery tomorrow

19 Mar

Data is a pharmaceutical company’s biggest asset. A recent report by Ovum has highlighted that IT spending in the small pharma/biotech sector will total $10.5bn in 2017.  Investing in technology which allows firms to collect, manage and analyze vast amounts of data from numerous sources is an investment that can only pay off.

Continue Reading »

Meeting today’s chemistry data requirements

23 Jan

Chemists are always working with an end goal in mind – to efficiently conduct research to reach a desired result. They need tools to plan, execute and record reactions. They want to easily coordinate the testing of their products with other team members. Fast assay turnaround is a must, as is access to experimental results to optimize reaction yield, chemical composition or a desired activity.

Continue Reading »

Does collaboration keep you up at night?

21 Oct

Collaboration often lies at the heart of great innovations. So why should the thought of collaborating keep anyone up at night? Businesses which collaborate effectively usually flourish over those operating in splendid isolation. However, issues around data security and intellectual property (IP) protection can undermine the collaborative process. Failing to address these concerns risks turning collaborations aimed at enhancing competitiveness into threats to IP and, ultimately, commercial survival. Securing IP, the lifeblood of any innovative organization, is paramount. If it’s your innovation, it’s all about protecting it, ensuring your IP isn’t undermined with a copied or diluted product, and being the first to market.

Continue Reading »

Blog/Book of LC-MS Bioanalysis

19 Aug

The first ever comprehensive guide to experimental methodology for LC-MC bioanalysis (BA) is due to be published shortly. Edited by experts from Novartis Institutes for Biomedical Research, the Handbook of LC-MS Bioanalysis* is the result of an impressive collaboration from across a wide spectrum of the BA community spanning global pharma, regulators including the FDA and technology vendors. The Handbook looks likely to become the authoritative source on scientific, regulatory, quality and technology levers within the BA space.

Continue Reading »

Filing a patent? Sooner is better!

1 Aug

Since the Leahy-Smith America Invents Act (AIA) was passed by Congress and was signed into law by President Obama in September 2011, the clock has been ticking on the current ‘First-to-Invent’ system. This will be a major change for US scientists, especially those working across the spectrum of research and development (R&D). The new system means that patents will be granted in line with a new ‘First-to-File’ approach rather than rewarding the first person to make the discovery. So — failing a spectacular last minute change of heart — patents will be awarded according to the speed of an application. This radical departure will mean the main focus no longer rests on documented data but shifts the emphasis on getting information together and into a format ready to file with the patent office — fast! This could also include any associated results necessary to support a claim.

Continue Reading »